| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 203,226 | 195,266 | 175,932 | 278,816 | | Cost of Revenue | 161,029 | 153,618 | 142,666 | 251,206 | | | Gross Profit | 42,197 | 41,648 | 33,266 | 27,610 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 65,838 | 52,979 | 53,841 | 71,869 | | Non Recurring | 17,009 | (14,569) | 14,569 | 59,657 | | Others | (15,812) | 15,812 |
-
| (13) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (24,838) | (12,574) | (35,144) | (103,903) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,780 | 3,349 | 3,811 | 35,826 | | Earnings Before Interest And Taxes | (22,058) | (9,225) | (31,333) | (68,077) | | Interest Expense | 9,760 | 9,838 | 9,740 | 18,318 | | Income Before Tax | (31,818) | (19,063) | (41,073) | (86,395) | | Income Tax Expense | 230 | 10,519 | (220) | 2,633 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (32,048) | (29,582) | (40,853) | (89,028) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,048) | (29,582) | (40,853) | (89,028) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,048) | ($29,582) | ($40,853) | ($89,028) |
|
0.53% Nasdaq 
Income Statement
